BioNTech (BNTX) is a publicly traded Healthcare sector company. As of August 19, 2026, BNTX trades at $93.12 with a market cap of $23.01B and a P/E ratio of 0.00. BNTX moved +1.28% today. Year to date, BNTX is -2.57%; over the trailing twelve months it is -17.59%. Its 52-week range spans $79.52 to $129.27. Analyst consensus is strong buy with an average price target of $124.58. Rallies surfaces BNTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest BNTX news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $93.12 |
| Market Cap | $23.01B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 2.13% |
| 52-Week High | $129.27 |
| 52-Week Low | $79.52 |
| Volume | 846.41K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
12 analysts cover BNTX: 0 strong buy, 10 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $124.58.